BAX and hepatocellular carcinoma: A recent study demonstrated that treatment of the hepatoma cell lines HepG2 and Bel7402 with germacrone promoted cell apoptosis, associated with the upregulation of bax and the downregulation of bcl-2, indicating that germacrone may have a potential role in the treatment of hepatocellular carcinoma (8).